AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+14.47%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.73B
AUM Growth
+$4.73B
(+8.1%)
Cap. Flow
+$208M
Cap. Flow
% of AUM
4.4%
Top 10 Holdings %
Top 10 Hldgs %
47.54%
Holding
160
New
25
Increased
29
Reduced
25
Closed
13
Top Buys
| 1 |
Intel
INTC
|
$51.2M |
| 2 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$43.8M |
| 3 |
argenx
ARGX
|
$41.3M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$38.5M |
| 5 |
ACHL
Achilles Therapeutics plc American Depositary Shares
ACHL
|
$37.3M |
Top Sells
| 1 |
GDS Holdings
GDS
|
$73M |
| 2 |
Zillow
Z
|
$58.3M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$52.2M |
| 4 |
Alibaba
BABA
|
$46.5M |
| 5 |
uniQure
QURE
|
$25.3M |
Sector Composition
| 1 | Healthcare | 82.42% |
| 2 | Consumer Discretionary | 10.44% |
| 3 | Technology | 2.06% |
| 4 | Communication Services | 0.94% |
| 5 | Real Estate | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $464M | 8.19% | 14,818,300 | – | – |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $418M | 7.38% | 71,178,364 | – | – |
|
|
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $296M | 5.23% | 850,000 -150,000 | -15% | -$52.2M |
|
4
Seer Inc
SEER
$115M
| $280M | 4.94% | 5,588,366 -252,545 | -4% | -$12.6M |
|
|
XLRN
5
DELISTED
Acceleron Pharma Inc.
XLRN
| $190M | 3.35% | 1,400,000 | – | – |
|
|
RUBY
6
DELISTED
Rubius Therapeutics, Inc
RUBY
| $129M | 2.29% | 4,883,791 +1,104,878 | +29% | +$29.3M |
|
|
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $124M | 2.19% | 725,000 +225,000 | +45% | +$38.5M |
|
|
8
argenx
ARGX
$43.6B
| $124M | 2.19% | 450,000 +150,000 | +50% | +$41.3M |
|
|
MORF
9
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $115M | 2.03% | 1,819,186 +167,500 | +10% | +$10.6M |
|
10
Fate Therapeutics
FATE
$120M
| $107M | 1.89% | 1,300,000 -100,000 | -7% | -$8.25M |
|
11
Alnylam Pharmaceuticals
ALNY
$58.5B
| $106M | 1.87% | 750,000 -50,000 | -6% | -$7.06M |
|
12
Scholar Rock
SRRK
$3.14B
| $101M | 1.79% | 2,000,000 -100,000 | -5% | -$5.07M |
|
13
BioNTech
BNTX
$24B
| $98.3M | 1.74% | 900,000 -100,000 | -10% | -$10.9M |
|
|
IGMS
14
DELISTED
IGM Biosciences
IGMS
| $86.3M | 1.52% | 1,125,000 -75,000 | -6% | -$5.75M |
|
15
Generation Bio
GBIO
$40.4M
| $80.1M | 1.42% | 2,814,191 | – | – |
|
16
TG Therapeutics
TGTX
$4.65B
| $72.3M | 1.28% | 1,500,000 | – | – |
|
17
Schrodinger
SDGR
$1.44B
| $60.8M | 1.07% | 797,445 | – | – |
|
|
KLRS
18
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
| $54.4M | 0.96% | 2,323,371 | – | – |
|
|
19
Intel
INTC
$107B
| $51.2M | 0.9% | +800,000 | New | +$51.2M |
|
|
SAGE
20
DELISTED
Sage Therapeutics
SAGE
| $48.7M | 0.86% | 650,000 +250,000 | +63% | +$18.7M |
|
|
IMA
21
ImageneBio, Inc. Common Stock
IMA
$150M
| $43.8M | 0.77% | +1,549,513 | New | +$43.8M |
|
22
Black Diamond Therapeutics
BDTX
$157M
| $39.9M | 0.71% | 1,646,517 | – | – |
|
23
ALX Oncology
ALXO
$62.7M
| $38.7M | 0.68% | 525,000 +225,000 | +75% | +$16.6M |
|
|
KRON
24
DELISTED
Kronos Bio
KRON
| $38.6M | 0.68% | 1,317,954 | – | – |
|
25
Krystal Biotech
KRYS
$4.27B
| $38.5M | 0.68% | 500,000 +262,500 | +111% | +$20.2M |
|